Vaccine Update for Healthcare Providers

Most Recent Articles

In the Journals: Nirsevimab

Published on

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

In the Journals: Adenovirus and VITT

Published on

Vaccine-induced thrombotic thrombocytopenia (VITT) has been shown to follow vaccination with COVID-19 adenovirus vector vaccines. Now, two research studies have shown that VITT also follows adenovirus infection. Find out more.

Vaccine Resources: Lots of New and Updated Resources

Published on

Check out the list of resources from the CDC and AAP, including interim recommendations for use of nirsevimab during the current shortage and updated Red Book chapter on use of PCV20.